dc.description.sponsorship | Acknowledgments. The ENIGMA project is in part supported by the National
Institute of Biomedical Imaging and Bioengineering of the NIH (U54EB020403).
The content is solely the responsibility of the authors and does not necessarily
represent the official views of the NIH. Individual Funding Sources: D.S., M.C.P.,
S.E.F., and C.F.: Max Planck Society (Germany). R.A.-A.: Miguel Servet contract
from the Carlos III Health Institute (CP18/00003). J.V.-B.: Instituto de Investigación
Sanitaria Valdecilla (IDIVAL) (INT/A21/10, INT/A20/04). D.A.: South-Eastern Norway
Regional Health Authority (2019107, 2020086). L.T.W.: Research Council of
Norway (223273, 300767), South-Eastern Norway Regional Health Authority
(2019101), and European Research Council under the European Union’s Horizon
2020 Research and Innovation Program (ERC StG, 802998). O.A.A.: Research
Council of Norway (223273, 275054), KG Jebsen Stiftelsen, South East
Norway Health Authority (2017-112, 2019-108). P.K.: NIH (R01MH123163,
R01EB015611). M.J.G.: National Health and Medical Research Council (NHMRC)
(630471, 1051672, 1081603). C.P.: NHMRC Senior Principal Research Fellowship
(1105825), NHMRC L3 Investigator Grant (1196508). V.D.C.: NIH (R01MH118695),
NSF (2112455). J.M.F.: Senior Research Career Scientist Award, Department of
Veterans Affairs. P.F.-C.: Centro de Investigación Biomédica en Red de Salud
Mental (CIBERSAM) and Instituto de Salud Carlos III, cofunded by European Union
(European Regional Development Fund (ERDF)/European Social Fund (ESF),
“Investing in your future”): Sara Borrell Research contract (CD19/00149). G.S.:
Italian Ministry of Health (RC17-18-19-20-21/A). A.N.V.: National Institute of
Mental Health (NIMH), Canadian Institutes of Health Research (CIHR), Canada
Foundation for Innovation, Centre for Addiction and Mental Health (CAMH)
Foundation, University of Toronto. Y.-C.C.: Korean Mental Health Technology R&D
Project (HL19C0015) and Korea Health Technology R&D Project through the Korea
Health Industry Development Institute (HI18C2383), funded by the Ministry of
Health & Welfare, Republic of Korea. J.M.S.: NIH (1P20RR021938-01). A.R.M.:
NIH (P30GM122734, R01MH101512). C.M.D.-C.: Instituto de Salud Carlos III,
Spanish Ministry of Science and Innovation (PI17/00481, PI20/00721,
JR19/00024). S. Cervenka: Swedish Research Council (523-2014-3467). M.
Kirschner: Swiss National Science Foundation (SNSF) (P2SKP3_178175). T.H.:
CIHR (142255), Ministry of Health of the Czech Republic (16-32791A, NU20-
04-00393), Brain & Behavior Research Foundation (BBRF) Young and Independent
Investigator Awards. A. James: Medical Research Council (MRC) (G0500092).
P.H.: NARSAD grant from the BBRF (28445), Research Grant from the
Novartis Foundation (20A058). R.C.G.: NIH (1R01MH117014, 1R01MH119219).
N.J.: NIH (R01MH117601). S.E.M.: NHMRC (APP1172917). J.A.T.: NIH (R01MH1
21246). Dataset-Specific Funding Sources and Acknowledgments: AMC:
Supported by grants from The Netherlands Organisation for Health Research and
Development (ZonMw) (3160007, 91676084, 31160003, 31180002, 31000056,
2812412, 100001002, 100002034), the Dutch Research Council (NWO)
(90461193, 40007080, 48004004, 40003330), the Amsterdam Brain Imaging
Platform, Neuroscience Campus Amsterdam, and the Dutch Brain Foundation.
Processing with FreeSurfer was performed on the Dutch e-Science Grid through
BiG Grid project and COMMIT project “e-Biobanking with imaging for healthcare,”
which are funded by the NWO. ASRB: Australian Schizophrenia Research Bank,
supported by the NHMRC (Enabling Grant, 386500), the Pratt Foundation,
Ramsay Health Care, the Viertel Charitable Foundation, and the Schizophrenia
Research Institute. Chief Investigators for ASRB were S.V.C., P.T.M., B.J.M., U.S.,
R.J.S., V.J.C., F.A.H., C.P., Assen Jablensky. We thank C.M.L., the ASRB Manager,
and acknowledge the help of Jason Bridge for ASRB database queries. CAMH:
Datasets were collected and shared with support from the CAMH Foundation and
the CIHR. CASSI (Cognitive and Affective Symptoms in Schizophrenia Intervention):
Downloaded from https://www.pnas.org by UNIVERSIDAD DE CANTABRIA BIBLIOTECA UNIV/OFIC.PBL.PER. on April 10, 2023 from IP address 193.144.191.20.
Supported by the University of New South Wales School of Psychiatry, the NHMRC (568807), Neuroscience Research Australia, the Schizophrenia Research Institute
utilizing infrastructure funding from NSW Ministry of Health, the Macquarie
Group Foundation, and the ASRB (see above). CIAM (Cortical Inhibition and
Attentional Modulation): The CIAM group (PI: F.M.H.) was supported by the
University Research Committee, University of Cape Town; South African National
Research Foundation (NRF); South African Medical Research Council (SA MRC).
CLING (Clinical Neuroscience Goettingen): Sample data collection partially supported by the Deutsche Forschungsgemeinschaft (DFG) (GR1950/5-1 to O.G.).
COBRE (Center for Biomedical Research Excellence): Supported by NIH
(R01EB006841, P20GM103472, 5R01MH094524 to V.D.C. and J.A.T.
R01AA021771 and P50AA022534 to J.M.S.), and the NSF (1539067).
EdinburghEHRS: Funded by the MRC (G9226254, G9825423), the Dr. Mortimer
and Theresa Sackler Foundation. EdinburghFunc: Funded by the MRC Clinical
Training Fellowship (G84/5699) and Health Foundation Clinician Scientist
Fellowship (2268/4295). EdinburghSFMH: Funded by an award from the
Translational Medicine Research Collaboration (NS_EU_166), Scottish Enterprise,
Pfizer, the Dr. Mortimer and Theresa Sackler Foundation. The University of
Edinburgh is a charitable body, registered in Scotland, with registration number
SC005336. Is e buidheann carthannais a th’ ann an Oilthigh Dhùn Èideann,
clàraichte an Alba, àireamh clàraidh SC005336. EONCKS: Supported by the SA
MRC and the New Partnership for Africa’s Development initiative through the
Department of Science and Technology of South Africa (#65174). ESO: Supported
by the Ministry of Health of the Czech Republic (NU20-04-00393). FBIRN
(Function Biomedical Informatics Research Network): Supported by the National
Center for Research Resources at the NIH (1 U24 RR021992 (FBIRN) and 1 U24
RR025736-01 (Biomedical Informatics Research Network Coordinating Center;
http://www.birncommunity.org)). Data were processed by the UCI HighPerformance Computing cluster supported by Joseph Farran (supported by NIMH
R01 MH-58262), Harry Mangalam, and Adam Brenner (supported by NIH 5R01
MH61603, 2R01MH058251), and the National Center for Research Resources
and the National Center for Advancing Translational Sciences, NIH (through grant
UL1 TR000153). FBIRN thank Mrs. Liv McMillan for overall study coordination.
FOR2107 Marburg: Funded by the DFG, T.T.J.K. (speaker FOR2107; KI588/14-1,
KI588/14-2), Axel Krug (KR3822/5-1, KR3822/7-2), I.N. (NE2254/1-2, NE2254/3-1,
NE2254/4-1), Carsten Konrad (KO4291/3-1), and A. Jansen (JA1890/7-1,
JA1890/7-2). FOR2107 Münster: Funded by the DFG (FOR2107 DA1151/5-1,
DA1151/5-2 to U.D.; SFB-TRR58, Projects C09 and Z02 to U.D.) and the
Interdisciplinary Center for Clinical Research of the medical faculty of Münster
(Dan3/012/17 to U.D.). Frankfurt: MRI was performed at the Frankfurt Brain
Imaging Centre, supported by the DFG and the German Ministry for Education
and Research (Brain Imaging Center Frankfurt/Main, DLR01GO0203). GAP
(Genetics and Psychosis): The GAP dataset represents independent research
funded by the National Institute for Health and Care Research (NIHR) Biomedical
Research Centre at South London, Maudsley National Health Service (NHS)
Foundation Trust, and King’s College London. The views expressed are those of
the author(s) and not necessarily those of the NHS, the NIHR, or the Department
of Health. GIPSI: Supported by “PRISMA U.T” Colciencias Invitación 990 del 3 de
Agosto de 2017, Código 111577757629, Contrato 781 de 2017. GROUP: We
thank Truda Driesen and Inge Crolla for their coordinating roles in the data collection, as well as the G.R.O.U.P. investigators: R.S.K., Don H. Linszen, Jim van Os,
Durk Wiersma, Richard Bruggeman, W.C., L.dH., Lydia Krabbendam, Inez MyinGermeys. Infrastructure for the GROUP study is funded through the Geestkracht
programme of ZonMw (10-000-1001), and matching funds from participating
pharmaceutical companies (Lundbeck, AstraZeneca, Eli Lilly, Janssen Cilag) and
universities and mental health care organizations (Amsterdam: Academic
Psychiatric Centre of the Academic Medical Center and the mental health institutions: GGZ Ingeest, Arkin, Dijk en Duin, GGZ Rivierduinen, Erasmus Medical
Centre, GGZ Noord Holland Noord; Groningen: University Medical Center
Groningen and the mental health institutions: Lentis, GGZ Friesland, GGZ Drenthe,
Dimence, Mediant, GGNet Warnsveld, Yulius Dordrecht and Parnassia psychomedical center, The Hague; Maastricht: Maastricht University Medical Centre and
the mental health institutions: GGzE, GGZ Breburg, GGZ Oost-Brabant, Vincent
van Gogh voor Geestelijke Gezondheid, Mondriaan, Virenze riagg, Zuyderland
GGZ, MET ggz, Universitair Centrum Sint-Jozef Kortenberg, CAPRI University of
Antwerp, PC Ziekeren Sint-Truiden, PZ Sancta Maria Sint-Truiden, GGZ Overpelt,
OPZ Rekem; Utrecht: University Medical Center Utrecht and the mental health
institutions Altrecht, GGZ Centraal, and Delta). HMS (Homburg Multidiagnosis Study): Sample data collection was supported by a grant of the Competence
Network Schizophrenia to O.G.. HUBIN (Human Brain Informatics): Supported by
the Swedish Research Council (K2015-62X-15077-12-3), 2017-00949, the
regional agreement on medical training and clinical research between Stockholm
County Council and the Karolinska Institutet, the Knut and Alice Wallenberg
Foundation. Huilong: Funded by the National Natural Science Foundation of
China (81761128021; 31671145; 81401115; 81401133), Beijing Municipal
Science & Technology Commission grant (Z141107002514016), Beijing Natural
Science Foundation (7162087), Beijing Municipal Administration of Hospitals
Clinical medicine Development of special funding (XMLX201609; zylx201409).
IGP: Imaging Genetics in Psychosis study, funded by Project Grants from the
NHMRC (APP630471 and APP1081603), and the Macquarie University’s ARC
Centre of Excellence in Cognition and its Disorders (CE110001021). This project
used participants from the ASRB (see above), using an infrastructure grant from
the NSW Ministry of Health. IMH: Supported by research grants from the National
Healthcare Group, Singapore (SIG/05004; SIG/05028), and the Singapore
Bioimaging Consortium (RP C009/2006) awarded to K.S. KaSP: Supported by
the Swedish Research Council (K2015-62X-15077-12-3), and by grants from the
Swedish Medical Research Council (2009-7053, 2013-2838, 523-2014-3467),
the Swedish Brain Foundation, Åhlén-siftelsen, Svenska Läkaresällskapet, Petrus
och Augusta Hedlunds Stiftelse, Torsten Söderbergs Stiftelse, the AstraZenecaKarolinska Institutet Joint Research Program in Translational Science, Söderbergs
Königska Stiftelse, Professor Bror Gadelius Minne, Knut och Alice Wallenbergs
stiftelse, the Swedish Federal Government under the LUA/ALF agreement (C.M.S.,
S. Cervenka), Centre for Psychiatry Research, KID-funding from the Karolinska
Institutet. Madrid: Supported by the Spanish Ministry of Science and Innovation,
Instituto de Salud Carlos III (SAM16PE07CP1, PI16/02012, PI19/024), cofinanced
by ERDF Funds from the European Commission, “A way of making Europe,”
CIBERSAM, Madrid Regional Government (B2017/BMD-3740 AGES-CM-2),
European Union Structural Funds, European Union Seventh Framework Program
(FP7-4-HEALTH-2009-2.2.1-2-241909—Project EU-GEI, FP7-HEALTH-2013-2.2.1-
2-603196—Project PSYSCAN, and FP7-HEALTH-2013-2.2.1-2-602478—Project
METSY), European Union H2020 Program under the Innovative Medicines
Initiative 2 Joint Undertaking (115916—Project PRISM, and 777394—Project
AIMS-2-TRIALS), Fundación Familia Alonso, Fundación Alicia Koplowitz. MCIC:
Supported by the NIH (NIH/NCRR P41RR14075, R01EB005846 to V.D.C.), the
Department of Energy (DE-FG02- 99ER62764), the Mind Research Network, the
Morphometry BIRN (1U24, RR021382A), the Function BIRN (U24RR021992-01,
NIH.NCRR MO1 RR025758-01, NIMH 1RC1MH089257 to V.D.C.), the DFG
(research fellowship to S.E.), and a NARSAD Young Investigator Award (to S.E.).
MPRC: Support received from NIH (U01MH108148, 2R01EB015611,
R01MH112180, R01DA027680, R01MH085646, P50MH103222, and
T32MH067533), a State of Maryland contract (M00B6400091), and NSF grant
(1620457). OLIN: Supported by NIH (R01MH106324, R01MH077945). Osaka:
Partially supported by AMED (JP21dm0307002, JP21dm0207069,
JP21dk0307103, JP21uk1024002, and JP21wm0425012), JSPS KAKENHI
(JP20H03611, JP20K06920), and Intramural Research Grant (3-1) for
Neurological and Psychiatric Disorders of NCNP. Computations were performed
using Research Center for Computational Science, Okazaki, Japan. Oxford: We
would like to thank the participants and their families, referring psychiatrists, and
the Donnington Health Centre, Oxford. This study is supported by the MRC,
OHSRC, UK EPSRC, BBSRC, and Wellcome Trust. PAFIP: We wish to thank all PAFIP
research teams and all patients and family members who participated in the
study. PAFIP has been funded by Instituto de Salud Carlos III through the projects
PI14/00639, PI14/00918, and PI17/01056 (cofunded by ERDF/ESF “Investing in
your future”), Health Research Institute Marques de Valdecilla (NTC0235832,
NCT02534363), Instituto de Salud Carlos III, FIS 00/3095, 01/3129, PI020499,
PI060507, PI10/00183, the SENY Fundació Research Grant (CI 2005‐0308007),
the Fundación Marqués de Valdecilla (API07/011), MINECOSAF2013-46292-R,
PSYSCAN (Exp.: HEALTH.2013.2.2.1-2_Grant agreement no. 603196). We
want to particularly acknowledge the patients and the BioBankValdecilla
(PT13/0010/0024) integrated in the Spanish National Biobanks Network for its
collaboration. We thank IDIVAL Neuroimaging Unit for its help in the technical
execution of this work. RSCZ: Supported in part by the RFBR (20-013-00748).
SCORE: This study was supported in part by the SNSF (3232BO_119382). We
thank the FePsy (Frueherkennung von Psychosen; early detection of psychosis)
Downloaded from https://www.pnas.org by UNIVERSIDAD DE CANTABRIA BIBLIOTECA UNIV/OFIC.PBL.PER. on April 10, 2023 from IP address 193.144.191.20.
Study Group from the University of Basel, Department of Psychiatry, Switzerland, for the recruitment of the study participants. The FePsy Study was supported in part
by grant no. SNF 3200-057216/1, ext./2, ext./3. SNUH: Supported by the Basic
Science Research Program through the National Research Foundation of Korea (NRF)
and the Korea Brain Research Institute (KBRI) basic research program through the
KBRI, funded by the Ministry of Science, ICT & Future Planning (2019R1C1C1002457,
2020M3E5D9079910, 21-BR-03–01). SWIFT: Supported in part by the SNSF
(320030_146789). TOP: Supported by the Research Council of Norway (#160181,
190311, 223273, 213837, 249711), the South-East Norway Health Authority
(2014114, 2014097, 2017- 112), the Kristian Gerhard Jebsen Stiftelsen (SKGJ‐
MED‐008), and the European Community’s Seventh Framework Programme
(FP7/2007–2013), grant agreement no. 602450 (IMAGEMEND). UCISZ: Supported
by the NIMH (R21MH097196 to T.G.M.v.E.). Data were processed by the UCI HighPerformance Computing cluster (see FBIRN). UMCU: Supported by ZonMw
(90802123, 91746370 to H.E.H.P., and 10-000-1001 to R.S.K.). UNIBA: Supported
by grant funding from the Italian Ministry of Research (2017M7SZM8_004, PI A.B.;
2017K2NEF4, PI G.P.). UNIMAAS: Supported by ZonMw (91112002) and by a personal grant to T.v.A. (ZonMw-VIDI: 91712394). This clinical trial was registered in
the Dutch clinical trial registry under ID: NTR5094 (https://trialsearch.who.int/Trial2.
aspx?TrialID=NTR5094). Zurich: Funded by the SNSF. | es_ES |